Skip to main content
Plasmapp Co., Ltd. logo

Plasmapp Co., Ltd. — Investor Relations & Filings

Ticker · 405000 ISIN · KR7405000001 KO Manufacturing
Open in API
Filings indexed 214 across all filing types
Latest filing 2022-09-30 Capital/Financing Update
Country KR South Korea
Listing KO 405000

About Plasmapp Co., Ltd.

https://plasmapp.com/

Plasmapp Co., Ltd. is a company specializing in plasma engineering technology for the medical sector. Originating from the Korea Advanced Institute of Science and Technology (KAIST), the company develops and manufactures advanced plasma-based solutions. Its core offerings include low-temperature plasma sterilizers, such as the STERLINK series, designed for the rapid and safe sterilization of heat-sensitive medical instruments. In addition to sterilization and disinfection, Plasmapp provides technologies for surface treatment and regenerative activation to enhance the safety and efficacy of medical devices, including implants, aiming to improve infection control and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 1% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by Plasmaps. It details specific amendments to a previous registration statement, including updates to underwriting procedures, risk factors, and capital structure details related to an IPO. In the context of financial filings, a Securities Registration Statement (and its amendments) is a regulatory filing that provides comprehensive information about a company's public offering. Since it does not fit into the specific categories like '10-K' (Annual Report) or 'ER' (Earnings Release), and is a formal regulatory document rather than a simple announcement, it falls under the 'Regulatory Filings' category.
2022-09-30 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 1% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) for Plazmap, filed with the Korean financial authorities. It details changes to the public offering schedule, subscription dates, and various disclosures within the original registration statement. This document is a formal regulatory filing related to a capital raise (IPO) and its subsequent amendments, which falls under the category of Regulatory Filings (RNS) as it is a formal legal filing with a regulatory body.
2022-09-08 Korean
증권신고서(지분증권)
Share Issue/Capital Change Classification · 1% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details the company's (Plasmapp) intent to offer shares, provides investment risk factors, and outlines the offering process. This is a formal regulatory filing required for public offerings, which falls under the category of Regulatory Filings (RNS) as it is a specific legal document for securities registration that does not fit into the other specialized categories like 10-K or Earnings Release.
2022-08-19 Korean
감사보고서 (2021.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Plasmab' (주식회사 플라즈맵) for the fiscal year ending December 31, 2021. It includes the independent auditor's opinion, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a comprehensive financial audit document, not an earnings release or a simple announcement, fitting the definition of an Audit Report (AR). FY 2021
2022-04-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.